Insider plans sale of 6,189 common shares

Nauman Toor plans to sell 6,189 shares of INOD common stock through Raymond James & Associates on or around 01/15/2026, with an aggregate market value of 402,285.00.

Rhea-AI Filing Summary

Nauman Toor plans to sell 6,189 shares of INOD common stock through Raymond James & Associates on or around 01/15/2026, with an aggregate market value of 402,285.00. The shares relate to a stock option exercise dated 03/10/2022, paid in cash on 01/02/2026. The issuer had 31,848,000 common shares outstanding when this notice was prepared.

Over the past three months, Toor has already sold common shares of the same issuer in several transactions, including 16,162 shares for gross proceeds of 1,050,530.00, 122,264 shares for 7,958,036.00, and 5,385 shares for 350,034.00. By signing, Toor represents that he is not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many INOD shares does Nauman Toor currently plan to sell under this notice?

The notice states that 6,189 shares of INOD common stock are planned to be sold through Raymond James & Associates, with an aggregate market value of 402,285.00.

On what date is the planned INOD share sale expected to occur?

The approximate date of sale listed for the planned transaction is 01/15/2026, with the shares to be sold on the NASDAQ exchange.

What is the origin of the 6,189 INOD shares being sold by Nauman Toor?

The 6,189 common shares were acquired via a stock option exercise from the issuer on 03/10/2022, with payment in cash made on 01/02/2026.

How many INOD shares were outstanding when this planned sale was disclosed?

The filing indicates that there were 31,848,000 shares of INOD common stock outstanding at the time this notice was prepared.

What INOD share sales has Nauman Toor made in the past three months?

In the past three months, Nauman Toor sold common shares in several transactions, including 16,162 shares for 1,050,530.00, 122,264 shares for 7,958,036.00, and 5,385 shares for 350,034.00.

What representation does Nauman Toor make about information on INOD in this notice?

By signing the notice, Toor represents that he does not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/15/2026 - 02:48 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001723873
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	INNODATA INC
SEC File Number	001-35774
Address of Issuer	55 CHALLENGER ROAD SUITE 202 RIDGEFIELD PARK NEW JERSEY 07660
Phone	201 371 8000
Name of Person for Whose Account the Securities are To Be Sold	Toor Nauman Sabeeh
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former Chairman of the Board

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	RAYMOND JAMES & ASSOCIATES 880 CARILLON PARKWAY ST. PETERSBURG FL 33716	6189	402285.00	31848000	01/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	03/10/2022	STOCK OPTION EXERCISE	ISSUER			6189	01/02/2026	CASH

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
NAUMAN TOOR 3716 CAESARS CIR LAS VEGAS NV 89120	COMMON	01/08/2026	16162	1050530.00
NAUMAN TOOR 3716 CAESARS CIR LAS VEGAS NV 89120	COMMON	01/09/2026	122264	7958036.00
NAUMAN TOOR 3716 CAESARS CIR LAS VEGAS NV 89120	COMMON	01/13/2026	5385	350034.00

144: Remarks and Signature

Remarks
Date of Notice	01/15/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Maressia Rooks-Bailey, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Nauman Toor
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)